Medical · California, Colorado, Washington · 23 minutes ago
A Psychology Today commentary argues that commercial marijuana legalization has drifted far from its medical roots. It says today's high-potency products raise psychosis and cannabis use disorder risks, and that heavy users drive sales. It also cites an estimated $29.1 billion in 2025 US legal sales and compares the cannabis industry's marketing and lobbying to Big Tobacco's. Marijuana legalization is the focus.
Why it matters: The commentary reflects a growing public health argument that legal cannabis is a commercial product, not a medicine. For consumers and patients, it highlights the gap between dispensary products and tested medicines, and the potency trend. It also signals continued pressure for tighter marketing, potency and warning rules, though it is an opinion piece rather than a policy change.
Read moreSource: psychologytoday.com
Products · California · November 18, 2026
Cannabis cocktail parties are catching on in San Francisco, where Herbal Cocktail Co. staged a Moulin Rouge-themed event called Herbal Rouge. Guests sipped 2 mg THC mocktails, watched burlesque and sampled flower through vaporizers. Co-owner Jamie Evans says low-dose drinks give curious newcomers a sociable way into cannabis.
Why it matters: Low-dose THC drinks at 2 mg are pitched as a gentle, social entry point rather than a smoking session. For consumers, cannabis cocktail parties show where the beverage category is heading: themed events, trained bartenders and flavor-focused menus. Operators say dosing and taste questions remain, so newcomers are still sorting out what to expect from a cannabis cocktail.
Read moreSource: GreenState
Products · California, Massachusetts, New York · November 17, 2026
A High Times analysis by Vee Popat, a dispensary marketing specialist, finds that Google's dispensary rankings mostly reward proximity, complete listings and large review counts. Of 30 map spots in 10 U.S. cities, 20 went to shops with over 1,000 reviews. Several top-rated shops barely appeared, and some Ontario map listings could not be matched to licensing records.
Why it matters: A top Google result says a shop is nearby, has a tidy listing and has gathered many reviews. It says nothing about product freshness, staff knowledge or prices. In Ontario, a perfect rating was no proof of a license. Shoppers who want to confirm legitimacy are better served by official license lookups than by star ratings.
Read moreSource: High Times
Laws · California · November 17, 2026
A California lawsuit accuses Los Angeles dispensary LAX CC of embedding "spy pixels" in marketing emails. The plaintiff claims the code invaded their privacy under California law and fed data to brokers, tracking details like when emails are opened, location and forwarding.
Why it matters: If the claims hold up, a dispensary's marketing emails could be quietly collecting data on customers, including when they read messages and where they are. For shoppers, it raises questions about what retailers learn from sign-ups. These are allegations only, and no ruling has been made.
Read moreSource: WeedWeek
Profiles · California · November 16, 2026
Glass House Brands stock plunge continues after the California cannabis grower said it pushed out new auditor BDO and brought back MGO. Shares fell over 33% Thursday to about $1.25, then edged up to $1.29 Friday, still roughly 90% below the June 30 NYSE debut. BDO called its review of the deal behind the listing an unresolved issue.
Why it matters: Glass House and Trulieve showed that cannabis firms can reach the NYSE only by splitting off recreational operations, and the early results are poor. For consumers, that signals that investor money is waiting on federal rules covering adult-use cannabis, so company stability and funding for brands you buy may stay uncertain for now.
Read moreSource: finance.yahoo.com
Laws · California, Missouri, Ohio · November 15, 2026
Federal hemp seed rules change on December 11, and cannabis seed legality will turn on the THC of the plant that produced it. Under Section 781, seeds from plants above 0.3% total THC stop counting as hemp. Seed sellers are shifting US orders offshore and toward clones and tissue culture, and federal enforcement guidance is still missing.
Why it matters: For home growers, mail-order seeds with high-THC genetics may become legally risky or harder to find, since sellers rarely test the parent plant. Growers in states without legal cannabis look most exposed. Clones and tissue culture may fill part of the gap, but whether they qualify under the new test is still unresolved.
Read moreSource: High Times
The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report
Medical · California · November 13, 2026
Cannabis consumers trust dispensary staff and healthcare providers far more than government for cannabis information, according to a new survey of 1,023 adults. Researchers from UC San Francisco and Johns Hopkins asked respondents to rate sources from 1 to 5. State and federal officials ranked near the bottom, and social media users ranked last.
Why it matters: Most consumers get guidance on dosing, effects and medical use from budtenders and clinicians, not from public agencies. That puts real weight on the training and accuracy of dispensary staff and doctors. It also suggests government safety messaging on cannabis may struggle to reach the people it targets, since many consumers discount it.
Read moreSource: norml.org
Laws · California · November 13, 2026
Auburn City Council voted to rezone parts of the city for cannabis dispensaries, but left out downtown. Three zones along Highway 49 are now approved for retail. Council members dropped the downtown zone after traffic and neighborhood concerns. The city's cannabis dispensary ordinance, expected next month, would lift its ban and allow one retail permit.
Why it matters: For Auburn-area consumers, a legal local store is closer but still not here. The city plans one permit at first, capped at two, and a fee and application process is still to come. Limited commercial space on Highway 49 could slow the opening, so buyers may keep using delivery for now.
Read moreSource: abridged.org
Medical · California · November 12, 2026
Frequent cannabis use is linked to a lower chance of a glaucoma diagnosis, according to a case-control study in the Journal of Glaucoma. University of California San Diego researchers compared over 5,000 patients with over 20,000 controls and found marijuana use tied to lower odds of primary open-angle glaucoma, with the effect growing alongside use.
Why it matters: The finding is an association, not proof that cannabis protects eyes, and the authors call only for more research into cannabis components as add-on therapies. Cannabis is known to lower eye pressure only temporarily, and the American Glaucoma Society still does not endorse it as treatment, so patients should not read this as a green light.
Read moreSource: NORML
Medical · California · November 12, 2026
A survey of 1,023 adult consumers shows people looking for cannabis information put little faith in government sources. Researchers from UC San Francisco and Johns Hopkins found dispensary staff and healthcare providers rated most trustworthy, followed by friends and family. Social media users ranked last, and state and federal officials landed near the bottom.
Why it matters: Public health agencies that want to reach cannabis consumers have a credibility problem, according to these results. People are getting their information at the counter and in the clinic, so the accuracy of what budtenders and doctors say carries real weight. Patients seeking therapeutic guidance mostly lean on healthcare providers, not official websites or campaigns.
Read moreSource: NORML